The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

VSIG2  -  V-set and immunoglobulin domain containing 2

Homo sapiens

Synonyms: 2210413P10Rik, CT-like protein, CTH, CTXL, Cortical thymocyte-like protein, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of VSIG2

  • The calcitonin-like immunoreactivity (CT-like immunoreactivity) was measured in blood aspirated from the vascular bed of the anterior pituitary gland during transsphenoidal surgery in 33 patients with PRL-producing microadenomas, 2 patients with Cushing's disease, and 1 patient with metastatic breast cancer with a normal pituitary gland [1].
  • Inhibition of the second exteroceptive suppression of temporalis muscle activity (ES2) produced by a preceding electrical stimulus applied at the index was studied in patients suffering from migraine without aura (MO), chronic (CTH) or episodic (ETH) tension-type headache [2].
  • These results suggest that a locally secreted CT-like peptide(s) induces mitogenic responses in prostate cancer cells [3].
  • BACKGROUND: Fabry disease is an X-linked inherited disorder that is caused by excessive lysosomal globotriaosylceramide (CTH) storage due to a deficiency in alpha-galactosidase A (alpha-Gal A) [4].
  • If its anabolic effects are ultimately found to be separable and additive to CT's basic action to inhibit bone resorption, new approaches to osteoporosis prevention, and possibly other treatment situations such as cartilage regeneration, may evolve using novel CT-like molecules [5].
 

High impact information on VSIG2

  • Thus, 20 CT or CT-like genes were identified, with several exhibiting expression in five or more of the cancer cell lines examined [6].
  • In this study, we have carried out large-scale extractions from Sprague-Dawley rat brain diencephalon and pituitary, and purified a novel, biologically active, CT-like peptide from pituitary [7].
  • Finally, IUF1 was shown to be immunologically related to a recently cloned factor, IPF1, that binds to a CT-like sequence in the rat insulin I gene promoter [8].
  • Recent studies have mapped a glucose response element to a CT-like sequence in the rat insulin I gene [8].
  • In vitro, rat pituitaries in a serum-free medium did not release measurable amounts of immunoreactive CT-like material even when medium contained high Ca (2.5 mM), high K (25 mM), or TRH (10(-6) M) [9].
 

Biological context of VSIG2

  • We also identified a common single nucleotide polymorphism (SNP), namely c.1364G>T (S403I) in exon 12 of CTH [10].
  • BACKGROUND: Chymotrypsin (CT) and CT-like enzymes contribute to the dynamics of metabolism by their participation in digestion, peptide hormone generation and catabolism, fertilization of ova and inhibition of thrombin-induced platelet aggregation, among other processes [11].
  • The "in vitro" 5HT binding curves to lymphocytes and monocytes of tension-type headache patients show a constant trend; during headaches, both CTH and ETH patients present a desensitization phenomenon with a complete loss of high affinity binding sites for 5HT [12].
  • CTH 1364T/T homozygotes had significantly higher mean plasma tHcy concentration than subjects with other genotypes, and the effect sizes of CTH and MTHFR genotypes were similar [10].
  • At the FL site, greater biomass was found in the CTH than in the WTH treatment 15 years after harvest, and this effect is attributed to be due to differences in understory competition [13].
 

Anatomical context of VSIG2

  • The present studies were undertaken to examine whether iSCT (immunoreactive salmon CT-like human peptide) co-exists with iHCT (thyroid CT-like substance) in human prostate tissue extracts, and whether these substances are secreted by primary prostate cells in culture [14].
  • Accumulation of trihexosylceramide (CTH) in these foamy epithelial cells was confirmed with immunohistochemical staining with the use of anti-CTH monoclonal antibody [15].
  • These results clearly show that a salmon CT-like immunoreactive molecule is present in pigeon hypothalamus and midbrain, in addition to its main locations in the UBG and thyroid gland [16].
  • Extracts of hypothalamus contained 31.5 +/- 9.65 ng/g wet weight as salmon CT-like immunoreactivity while extracts of midbrain and brain stem contained 17.0 +/- 5.00 and 2.85 +/- 2.1 ng/g wet weight respectively [16].
  • We studied the 5HT binding on surfaces of lymphocytes and monocytes in 26 tension-type headache patients (16 affected by chronic form (CTH) of the disease and 10 by episodic form (ETH] [12].
 

Associations of VSIG2 with chemical compounds

  • Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration [10].
  • Bis-dioxolene bridged dinuclear metal complexes of general formula M2(CTH)2(diox-diox)(PF6)n (n = 2, 3; M = Co(III), Cr(III); CTH = tetraazamacrocycle) have been synthesized using the bis-bidentate ligand 5,5'-di-tert-butyl-3,3',4,4'-tetrahydroxybiphenyl [17].
  • Recently, we discovered that cystathioninuria was caused by mutations in the CTH gene encoding cystathionine gamma-lyase, an enzyme that converts cystathionine to cysteine in the trans-sulfuration pathway [10].
  • Cerium (IV) trihydroxyhydroperoxide (CTH) was introduced as a packed oxidant before the analytical column for the conversion of methotrexate into highly fluorescent products [18].
  • Cerium (IV) trihydroxyhydroperoxide (CTH) was introduced as a packed oxidant before analytical column for the conversion of methotrexate into highly fluorescent 2,4-diaminopteridine derivatives [19].
 

Other interactions of VSIG2

  • G-CCK-like immunoreactivity was found in 97.6%; VIP-like immunoreactivity in 41%; CT-like immunoreactivity in 34%; GIP-like immunoreactivity in 10%; PP-like immunoreactivity in 40% and MT-like immunoreactivity in 60% of the samples [20].
 

Analytical, diagnostic and therapeutic context of VSIG2

References

  1. Calcitonin-like immunoreactivity in the pituitary vascular bed of man. Samaan, N.A., Leavens, M.E. J. Clin. Endocrinol. Metab. (1981) [Pubmed]
  2. Reduction of temporalis exteroceptive suppression by peripheral electrical stimulation in migraine and tension-type headaches. Wang, W., Schoenen, J. Pain (1994) [Pubmed]
  3. Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients. Shah, G.V., Rayford, W., Noble, M.J., Austenfeld, M., Weigel, J., Vamos, S., Mebust, W.K. Endocrinology (1994) [Pubmed]
  4. Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta. Linthorst, G.E., Hollak, C.E., Donker-Koopman, W.E., Strijland, A., Aerts, J.M. Kidney Int. (2004) [Pubmed]
  5. Effects of calcitonin on animal and in vitro models of skeletal metabolism. Wallach, S., Rousseau, G., Martin, L., Azria, M. Bone (1999) [Pubmed]
  6. Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Chen, Y.T., Scanlan, M.J., Venditti, C.A., Chua, R., Theiler, G., Stevenson, B.J., Iseli, C., Gure, A.O., Vasicek, T., Strausberg, R.L., Jongeneel, C.V., Old, L.J., Simpson, A.J. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  7. Purification of calcitonin-like peptides from rat brain and pituitary. Hilton, J.M., Mitchelhill, K.I., Pozvek, G., Dowton, M., Quiza, M., Sexton, P.M. Endocrinology (1998) [Pubmed]
  8. Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner. MacFarlane, W.M., Read, M.L., Gilligan, M., Bujalska, I., Docherty, K. Biochem. J. (1994) [Pubmed]
  9. Calcitonin-like immunoreactivity in rat and human pituitary glands: histochemical, in vitro, and in vivo studies. Cooper, C.W., Peng, T.C., Obie, J.F., Garner, S.C. Endocrinology (1980) [Pubmed]
  10. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Wang, J., Huff, A.M., Spence, J.D., Hegele, R.A. Clin. Genet. (2004) [Pubmed]
  11. Acetaldehyde inhibits chymotrypsin and serum anti-chymotrypsin activity. Brecher, A.S., Yang, M.P. J. Investig. Med. (1998) [Pubmed]
  12. Impairment of 5HT binding to lymphocytes and monocytes from tension-type headache patients. Giacovazzo, M., Bernoni, R.M., Di Sabato, F., Martelletti, P. Headache. (1990) [Pubmed]
  13. Effects of forest management on soil carbon: results of some long-term resampling studies. Johnson, D.W., Knoepp, J.D., Swank, W.T., Shan, J., Morris, L.A., Van Lear, D.H., Kapeluck, P.R. Environ. Pollut. (2002) [Pubmed]
  14. Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells. Shah, G.V., Noble, M.J., Austenfeld, M., Weigel, J., Deftos, L.J., Mebust, W.K. Prostate (1992) [Pubmed]
  15. A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Fukushima, M., Tsuchiyama, Y., Nakato, T., Yokoi, T., Ikeda, H., Yoshida, S., Kusumoto, T., Itoh, K., Sakuraba, H. Am. J. Kidney Dis. (1995) [Pubmed]
  16. Immunoreactive calcitonin in the central nervous system of the pigeon. Galan Galan, F., Rogers, R.M., Girgis, S.I., MacIntyre, I. Brain Res. (1981) [Pubmed]
  17. Charge distribution in bis-dioxolene radical metal complexes. synthesis and DFT characterization of dinuclear Co(III) and Cr(III) complexes with a mixed-valent, S = 1/2 semiquinone-catecholate ligand. Bencini, A., Daul, C.A., Dei, A., Mariotti, F., Lee, H., Shultz, D.A., Sorace, L. Inorganic chemistry. (2001) [Pubmed]
  18. Rapid determination of methotrexate in plasma by high-performance liquid chromatography with on-line solid-phase extraction and automated precolumn derivatization. Emara, S., Askal, H., Masujima, T. Biomed. Chromatogr. (1998) [Pubmed]
  19. On-line precolumn derivatization for HPLC determination of methotrexate using a column packed oxidant. Emara, S., Razee, S., Khedr, A., Masujima, T. Biomed. Chromatogr. (1997) [Pubmed]
  20. Peptides of the APUD system in amphibian skins. de Magistris, L., Annibale, B., Delle Fave, G., Salera, M., Puoti, M., Giordano, E., Forte, A., Erspamer, V. Peptides (1985) [Pubmed]
  21. Extraction of a substance with calcitonin-like immunoreactivity from pituitary glands of intact and thyroidectomized rats. Bone, H.G., Catherwood, B.D., Deftos, L.J. Calcif. Tissue Int. (1983) [Pubmed]
  22. Calcitonin gene-related peptide in the human thyroid, pituitary and brain. Tschopp, F.A., Tobler, P.H., Fischer, J.A. Mol. Cell. Endocrinol. (1984) [Pubmed]
  23. Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study. Zaidi, M., Fuller, K., Bevis, P.J., GainesDas, R.E., Chambers, T.J., MacIntyre, I. Calcif. Tissue Int. (1987) [Pubmed]
  24. Pituitary immunoreactive calcitonin-like material: lack of evidence for cross-reactivity with pro-opiomelanocortin. Gagel, R.F., O'Briain, D.S., Voelkel, E.F., Wolfe, H.J., DeLellis, R.A., Lee, A.K., Tashjian, A.H. Metab. Clin. Exp. (1983) [Pubmed]
 
WikiGenes - Universities